Assessment of a 60-Biomarker Health Surveillance Panel (HSP) on Whole Blood from Remote Sampling Devices by Targeted LC/MRM-MS and Discovery DIA-MS Analysis
Open Access
- 30 June 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in Analytical Chemistry
- Vol. 95 (29) , 11007-11018
Abstract
Telehealth, accessing healthcare and wellness remotely, should be a cost-effective and efficient way for individuals to receive care. The convenience of having a reliable remote collection device for blood tests will facilitate access to precision medicine and healthcare. Herein, we tested a 60-biomarker health surveillance panel (HSP), containing 35 FDA/LDT assays and covering at least 14 pathological states, on 8 healthy individuals' ability to collect their own capillary blood from a lancet finger prick and directly compared it to the traditional phlebotomist venous blood and plasma collection methods. All samples were spiked with 114 stable-isotope-labeled (SIL) HSP peptides and quantitatively analyzed by liquid chromatography-multiple reaction monitoring-mass spectrometry (LC/MRM-MS) scheduled method targeting 466 transitions from 114 HSP peptides and by a discovery data-independent acquisition mass spectrometry (DIA-MS) method. The average peak area ratio (PAR) of the HSP quantifier peptide transitions from all 8 volunteers' capillary blood (n = 48), venous blood (n = 48), and matched plasma (n = 24) was 90% similarity. Discovery DIA-MS analysis of the same samples using a plasma spectral library and a pan-human spectral library identified 1121 and 4661 total proteins, respectively. In addition, at least 122 FDA-approved biomarkers were identified. DIA-MS analysis reproducibly quantitated (<30% CV) ∼600-700 proteins in capillary blood, ∼800 proteins in venous blood, and ∼300-400 proteins in plasma, demonstrating that an expansive biomarker panel is possible with current mass spectrometry technology. Both targeted LC/MRM-MS and discovery DIA-MS analysis of whole blood collected on remote sampling devices are viable options for personal proteome biosignature stratification in precision medicine and precision health.Keywords
All Related Versions
This publication has 52 references indexed in Scilit:
- Highly Reproducible Automated Proteomics Sample Preparation Workflow for Quantitative Mass SpectrometryJournal of Proteome Research, 2017
- Revisiting biomarker discovery by plasma proteomicsMolecular Systems Biology, 2017
- A guide to aid the selection of diagnostic testsBulletin of the World Health Organization, 2017
- Application of volumetric absorptive microsampling for robust, high-throughput mass spectrometric quantification of circulating protein biomarkersClinical Mass Spectrometry, 2017
- Quantitative variability of 342 plasma proteins in a human twin populationMolecular Systems Biology, 2015
- A repository of assays to quantify 10,000 human proteins by SWATH-MSScientific Data, 2014
- Analytical Validation Considerations of Multiplex Mass-Spectrometry-Based Proteomic Platforms for Measuring Protein BiomarkersJournal of Proteome Research, 2014
- Plasma Proteome Database as a resource for proteomics research: 2014 updateNucleic Acids Research, 2013
- Multiple Reaction Monitoring (MRM)Circulation: Cardiovascular Genetics, 2012
- Automated approach for quantitative analysis of complex peptide mixtures from tandem mass spectraNature Methods, 2004